Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan

Microbiology and Immunology

Volumn 51, Issue 3, 2007, Pages 271-277

  Ohara, Masaru ^a   Kouda, Shuntaro ^a   Onodera, Makoto ^b   Fujiue, Yoshihiro ^c   Sasaki, Megumi ^d   Kohara, Tadahiro ^e   Kashiyama, Seiya ^f   Hayashida, Shizue ^g   Kadono, Manami ^h   Komatsuzawa, Hitoshi ^a   Gotoh, Naomasa ^h   Usui, Tuguru ^a   Itaha, Hideyuki ^b   Kuwabara, Masao ^c   Yokoyama, Takashi ⁱ   Sugai, Motoyuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c Hiroshima Prefecture Hiroshima Hospital   (Japan)

^d HIROSHIMA CITY HOSPITAL   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^f Saiseikai Hiroshima Hospital   (Japan)

^g JA HIROSHIMA GENERAL HOSPITAL   (Japan)

^h KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

ⁱ Hiroshima City Medical Association   (Japan)

Author keywords

Drug resistance; Metallo lactamase; Molecular epidemiology; Pseudomonas aeruginosa

Indexed keywords

IMIPENEM; LEVOFLOXACIN; METALLO BETA LACTAMASE;

ARTICLE; BACTERIAL STRAIN; CLUSTER ANALYSIS; ENZYME SYNTHESIS; JAPAN; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

PSEUDOMONAS AERUGINOSA;

EID: 33947416080     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03908.x     Document Type: Article

References (28)

1. Bush, K. 2001. New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32: 1085-1089.
2. GIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob. Agents Chemother. 48: 4654-4661.
3. IMP. Antimicrob. Agents Chemother. 42: 2006-2011.
4. Kimura, S., Alba, J., Shiroto, K., Sano, R., Niki, Y., Saesaki, S., Akizawa, K., Kaku, M., Watanuki, Y., Ishii, Y., and Yamaguchi, K. 2005. Clonal diversity of metallo-β-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J. Clin. Microbiol. 43: 458-461.
5. Kurokawa, H., Yagi, T., Shibata, N., Shibayama, K., and Arakawa, Y. 1999. Worldwide proliferation of carbapenem-resistant Gram-negative bacteria. Lancet 354: 955.
6. Levy, S.B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. Symp. Ser. Appl. Microbiol. 31: 65S-71S.
7. Livermore, D.M. 2001. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother. 47: 247-250.
8. Livermore, D.M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584.
9. Livermore, D.M., and Woodford, N. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol. 3: 489-495.
10. Lomovskaya, O., Warren, M.S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., and Lee, V.J. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combintaion therapy. Antimicrob. Agents Chemother. 45: 105-116.
11. Murphy, T.A., Simm, A.M., Toleman, M.A., Jones, R.N., and Walsh, T.R. 2003. Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47: 582-587.
12. Nishio, H., Komatsu, M., Shibata, N., Shimakawa, K., Sueyoshi, N., Ura, T., Satoh, K., Toyokawa, M., Nakamura, T., Wada, Y., Orita, T., Kofuku, T., Yamasaki, K., Sakamoto, M., Kinoshita, S., Aihara, M., and Arakawa, Y. 2004. Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J. Clin. Microbiol. 42: 5256-5263.
13. Nordmann, P., and Poirel, L. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8: 321-331.
14. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3: 255-264.
15. Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D.E., and Bianco, N. 1996. Expression of the multidrug resistance operon mexA-mexB- oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40: 2021-2028.
16. VIM-4. J. Antimicrob. Chemother. 51: 1409-1414.
17. Renau, T.E., Leger, R., Filonova, L., Flamme, E.M., Wang, M., Yen, R., Madsen, D., Griffith, D., Chamberland, S., Dudley, M.N., Lee, V.J., Lomovskaya, O., Watkins, W.J., Ohta, T., Nakayama, K., and Ishida, Y. 2003. Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 13: 2755-2758.
18. Renau, T.E., Leger, R., Flamme, E.M., Sangalang, J., She, M.W., Yen, R., Gannon, C.L., Griffith, D., Chamberland, S., Lomovskaya, O., Hecker, S.J., Lee, V.J., Ohta, T., and Nakayama, K. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42: 4928-4931.
19. Renau, T.E., Leger, R., Yen, R., She, M.W., Flamme, E.M., Sangalang, J., Gannon, C.L., Chamberland, S., Lomovskaya, O., and Lee, V.J. 2002. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 12: 763-766.
20. Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K., Kato, N., and Ohta, M. 1996. Multifocal outbreaks of metallo-β- lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40: 349-353.
21. Shibata, N., Doi, Y., Yamane, K., Yagi, T., Kurokawa, H., Shibayama, K., Kato, H., Kai, K., and Arakawa, Y. 2003. PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41: 5407-5413.
22. Clinical and Laboratory Standards Institute: CLSI Fifteenth informational supplement, M100-S15, 2005.
23. Toleman, M.A., Simm, A.M., Murphy, T.A., Gales, A.C., Biedenbach, D.J., Jones, R.N., and Walsh, T.R. 2002. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J. Antimicrob. Chemother. 50: 673-679.
24. Walsh, T.R., Toleman, M.A., Poirel, L., and Nordmann, P. 2005. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18: 306-325.
25. Yamaguchi, T., Yokota, Y., Terajima, J., Hayashi, T., Aepfelbacher, M., Ohara, M., Komatsuzawa, H., Watanabe, H., and Sugai, M. 2002. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J. Infect. Dis. 185: 1511-1516.
26. Yamasaki, K., Komatsu, M., Yamashita, T., Shimakawa, K., Ura, T., Nishio, H., Satoh, K., Washidu, R., Kinoshita, S., and Aihara, M. 2003. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo-β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J. Antimicrob. Chemother. 51: 631-638.
27. VIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob. Agents Chemother. 48: 626-628.
28. VIM-2 metallo-beta- lacatamase gene in Akita prefecture, Japan. Jpn. J. Infect. Dis. 57: 130-132.